60 related articles for article (PubMed ID: 23270582)
1. B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn.
Herishanu Y; Polliack A
Leuk Lymphoma; 2013 Jun; 54(6):1125-6. PubMed ID: 23270582
[No Abstract] [Full Text] [Related]
2. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
4. SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL).
Philippen A; Diener S; Zenz T; Döhner H; Stilgenbauer S; Mertens D
Br J Haematol; 2010 Sep; 150(5):633-6. PubMed ID: 20528870
[No Abstract] [Full Text] [Related]
5. Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.
Song Z; Lu P; Furman RR; Leonard JP; Martin P; Tyrell L; Lee FY; Knowles DM; Coleman M; Wang YL
Clin Cancer Res; 2010 Jan; 16(2):587-99. PubMed ID: 20068106
[TBL] [Abstract][Full Text] [Related]
6. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
8. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.
Laurenti L; Petlickovski A; Rumi C; Gobessi S; Piccioni P; Tarnani M; Puggioni P; Marietti S; Sica S; Leone G; Efremov DG
Haematologica; 2005 Nov; 90(11):1533-40. PubMed ID: 16266901
[TBL] [Abstract][Full Text] [Related]
10. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib targets BCR kinases and blocks migratory and microenvironmental survival signals in CLL cells.
López-Guerra M; Xargay-Torrent S; Pérez-Galán P; Saborit-Villarroya I; Rosich L; Villamor N; Aymerich M; Roué G; Campo E; Montserrat E; Colomer D
Leukemia; 2012 Jun; 26(6):1429-32. PubMed ID: 22182921
[No Abstract] [Full Text] [Related]
12. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction.
Zoller KE; MacNeil IA; Brugge JS
J Immunol; 1997 Feb; 158(4):1650-9. PubMed ID: 9029101
[TBL] [Abstract][Full Text] [Related]
13. The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.
de Gorter DJ; Reijmers RM; Beuling EA; Naber HP; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Blood; 2008 Apr; 111(7):3364-72. PubMed ID: 18227351
[TBL] [Abstract][Full Text] [Related]
14. Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display.
Schmitz R; Baumann G; Gram H
J Mol Biol; 1996 Aug; 260(5):664-77. PubMed ID: 8709147
[TBL] [Abstract][Full Text] [Related]
15. The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.
Grzywnowicz M; Karabon L; Karczmarczyk A; Zajac M; Skorka K; Zaleska J; Wlasiuk P; Chocholska S; Tomczak W; Bojarska-Junak A; Dmoszynska A; Frydecka I; Giannopoulos K
Leuk Lymphoma; 2015; 56(10):2908-13. PubMed ID: 25682964
[TBL] [Abstract][Full Text] [Related]
16. Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fc epsilon receptors.
Amoui M; Dráberová L; Tolar P; Dráber P
Eur J Immunol; 1997 Jan; 27(1):321-8. PubMed ID: 9022035
[TBL] [Abstract][Full Text] [Related]
17. Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
Boelens J; Lust S; Van Bockstaele F; Van Gele M; Janssens A; Derycke L; Vanhoecke B; Philippé J; Bracke M; Offner F
Leuk Res; 2009 Oct; 33(10):1335-43. PubMed ID: 19297020
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
20. Coupling Ca2+ store release to Icrac channel activation in B lymphocytes requires the activity of Lyn and Syk kinases.
Chung SC; Limnander A; Kurosaki T; Weiss A; Korenbrot JI
J Cell Biol; 2007 Apr; 177(2):317-28. PubMed ID: 17452533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
